Amy Page

Dr, PhD MClinPharm GradDipBiostat GradCertHProfEd BPharm BHSci AdvPracPharm GStat GAICD FSHPA FPS

  • The University of Western Australia (M315), 35 Stirling Highway,

    6009 Perth


  • 2609

Personal profile


Deprescribing, Quality Use of Medicines, Geriatrics


Dr Amy Page is a consultant pharmacist and qualified biostatistician. Her vision is to reduce medicines-related harm while balancing symptom control to align with individualised treatment goals for older people to improve well-being. She undertakes knowledge creation and translation through implementation, practitioner development, communication and media, engagement with professional bodies and policy for sustained impact on pharmacy practice.

She has received over $5 million in research funding and published over 140 articles including more than 100 peer reviewed papers. She has presented on medicine safety and the quality use of medicines for older people nationally and internationally. Her research is frequently profiled in the professional and lay media.

She has worked in patient-facing roles across many settings including community, hospital, medication reviews, Aboriginal community-controlled health service and general practice. She was one of the first Australian pharmacists to work within a general practice to optimise medicines use among people with multimorbidty and polypharmacy. She was the inaugural Lead Pharmacist Rehabilitation Aged and Community Care Services at Alfred Health leading pharmacy services at the subacute campus, where she held a senior management position within Alfred Health's pharmacy team for four years. She continues to work in community pharmacy and undertake medication reviews.

She has held multiple policy, governance and regulatory positions nationally and internationally. She served on the Council of Pharmacy Schools as a deputy councillor and worked on national standards including the NPS Prescribing Competencies, the APC Aged Care and Medication Management Review accreditation standards and the APC Pharmacist Prescribing accreditation standards. She consulted on the International Pharmacy Federation's Global Competency Framework. She has been a practitioner member of the Pharmacy Board of Australia from 2022 to current. She has served on the Pharmaceutical Society of Australia's state branch committee since 2017 where she is the current state president and serves on the national board of directors.

Dr Page has been consistently recognised by the Australian Journal of Pharmacy as one of the most influential people in pharmacy since 2017, most recently in December 2022. She was honoured to receive the 2022 Vice Chancellor's Early Career Researcher award and the 2023 School Research Impact and Innovation award. She was awarded the PSA Young Pharmacist of the Year in 2015.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities

Education/Academic qualification


Award Date: 23 Oct 2017

Research expertise keywords

  • Clinical pharmacology and ageing


Dive into the research topics where Amy Page is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or